*This page is updated as new information becomes available.
Health Authority COVID-19 Therapeutic Update (CTC/CTRAWG) | Updated May-30-2023
COVID Testing Guidance and Treatment for Clinicians (Word/PDF) | Updated: Jan-25-2023
OUT-PATIENT THERAPY GUIDE FOR MILD TO MODERATE COVID-19 PATIENTS
Click below for consolidated guidance from the BC CDC and the Health Authorities for emergency practitioners providing out-patient therapy for mild to moderate COVID-19 patients. Maximizing treatment for high-risk patients will reduce unnecessary hospital admissions, potentially easing emergency crowding.
Providing Out-Patient Therapy for Mild to Moderate COVID-19 Patients Presenting to the Emergency Department
*To access the latest version of the COVID-19 Therapy Guide, click the link above on your computer and press Ctrl+Shift+Delete (PC) or Command+Shift+R (MacOS) to refresh your browser.
BC CDC GUIDELINES
See links below for information on caring for patients in hospital settings and patients with underlying health conditions. Links also contain treatment guidance and information about caring for vulnerable populations.
Clinical Care Guidelines | Hospital and Critical Care Guidelines
Infection Control and PPE | Patient Handouts
Health Care Provider Support | Exposures and Return to Work
Drug Treatment and Therapy Guidelines | Ethics
General Health Care Provider Information
TESTING GUIDANCE | Updated: Feb -02 -2022
The following guides have been updated (Feb 02, 2022) to align with the new eligibility criteria for the treatment of people with mild to moderate COVID-19.
BC COVID-19 Viral Testing Guidance
Testing & Lab Guidance Documents | When to Get a COVID 19 Test
TREATMENT INFORMATION | Updated: Feb -02 -2022
New clinical practice guidelines and tools for the management of patients with mild to moderate COVID-19 infection have been added (Feb-02-2022). to the BC CDC Treatments page for health professionals.
Sotrovimab & Nirmatrelvir/Ritonavir Therapies | Nirmatrelvir/Ritonavir (Paxlovid) Clinical Practice Guide
Practice Tool #1: Step-by-Step Assessment | Practice Tool #2: Definitions of Clinically Extremely Vulnerable (CEV)
Practice Tool #3: Drug-Drug Interactions and Contraindications
MED DISTRIBUTION | Updated: Feb -02 -2022
– Sotrovimab is distributed by health authorities.
– Paxlovid is limited to prescribers due to short supply.
– CAT-e line (COVID Antiviral Therapeutics e-team) delayed launch (looking at Feb 14).
– BCCA patients should go via BCCA to start (new system).
Related VHIA – Outpatient Treatment for COVID-19
Public Health Agency of Canada – Coronavirus disease (COVID-19): Outbreak Update
Join the Conversation